Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Endoh

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Biochemical Journal|July 17, 2009
High ambient glucose induces angiotensin-independent AT-1 receptor activation, leading to increases in proliferation and extracellular matrix accumulation in MES-13 mesangial cellsNaohiro Yano, Daisuke Suzuki, Masayuki Endoh, et al.
Nephron Extra|June 14, 2014
Kidney Diseases Enhance Expression of Tetraspanin-8: A Possible Protective Effect against Tubular InjuryTakashi Hirukawa, Qiong Wu, Kaichiro Sawada, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|November 19, 2019
Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trialFumi Furuhashi, Hiroaki Tanaka, Shintaro Maki, et al.
The Journal of Cell Biology|November 5, 2003
Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalitiesSatoru Yamazaki, Ryo Iwamoto, Kazuko Saeki, et al.
Journal of Clinical Medicine|June 19, 2019
Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II TrialShintaro Maki, Hiroaki Tanaka, Makoto Tsuji, et al.
BMJ Open|November 2, 2018
TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trialTakashi Umekawa, Shintaro Maki, Michiko Kubo, et al.
Clinical and Experimental Nephrology|May 19, 2009
Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapyNaoto Miura, Hirokazu Imai, Shogo Kikuchi, et al.
Journal of Nephrology|June 12, 2012
A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal diseaseTetsuya Kawamura, Kensuke Joh, Hideo Okonogi, et al.
Clinical and Experimental Nephrology|August 13, 2013
Overestimation of the risk of progression to end-stage renal disease in the poor prognosis' group according to the 2002 Japanese histological classification for immunoglobulin A nephropathyYoichi Miyazaki, Tetsuya Kawamura, Kensuke Joh, et al.
Nihon Jinzo Gakkai Shi|November 22, 2005
[Estimation of glomerular filtration rate by inulin clearance: comparison with creatinine clearance]Yoshimasa Orita, Fumitake Gejyo, Minoru Sakatsume, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Biochemical Journal|July 17, 2009
High ambient glucose induces angiotensin-independent AT-1 receptor activation, leading to increases in proliferation and extracellular matrix accumulation in MES-13 mesangial cellsNaohiro Yano, Daisuke Suzuki, Masayuki Endoh, et al.
Nephron Extra|June 14, 2014
Kidney Diseases Enhance Expression of Tetraspanin-8: A Possible Protective Effect against Tubular InjuryTakashi Hirukawa, Qiong Wu, Kaichiro Sawada, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|November 19, 2019
Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trialFumi Furuhashi, Hiroaki Tanaka, Shintaro Maki, et al.
The Journal of Cell Biology|November 5, 2003
Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalitiesSatoru Yamazaki, Ryo Iwamoto, Kazuko Saeki, et al.
Journal of Clinical Medicine|June 19, 2019
Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II TrialShintaro Maki, Hiroaki Tanaka, Makoto Tsuji, et al.
BMJ Open|November 2, 2018
TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trialTakashi Umekawa, Shintaro Maki, Michiko Kubo, et al.
Clinical and Experimental Nephrology|May 19, 2009
Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapyNaoto Miura, Hirokazu Imai, Shogo Kikuchi, et al.
Journal of Nephrology|June 12, 2012
A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal diseaseTetsuya Kawamura, Kensuke Joh, Hideo Okonogi, et al.
Clinical and Experimental Nephrology|August 13, 2013
Overestimation of the risk of progression to end-stage renal disease in the poor prognosis' group according to the 2002 Japanese histological classification for immunoglobulin A nephropathyYoichi Miyazaki, Tetsuya Kawamura, Kensuke Joh, et al.
Nihon Jinzo Gakkai Shi|November 22, 2005
[Estimation of glomerular filtration rate by inulin clearance: comparison with creatinine clearance]Yoshimasa Orita, Fumitake Gejyo, Minoru Sakatsume, et al.
Pageof 5